|
Monday 10 January |
|
Session 1: Epidemiology of HIV in Women and Girls |
|||
|
Invited lecture: Social and Structural correlates of risk for women |
K. Smith |
|
|
|
Agency among women engaging in transactional sex: Implications for HIV vulnerability |
Y. Zembe |
|
|
|
Regional differences in demographics, antiretroviral use, and virological response to therapy among HIV-positive women in a multi-site Canadian cohort |
A. Palmer |
|
|
|
HIV-positive women from adolescence through menopause accessing care and treatment in Central Africa |
J. Newman |
|
|
|
Comparison of HIV-positive women with children and without children accessing HIV care and treatment in the IeDEA Central Africa cohort |
A. Freeman |
|
|
|
Session 2: HIV prevention for Women (1) |
|||
|
Invited lecture: Genital immunology and HIV Transmission |
R. Kaul |
|
|
|
Invited lecture: Microbicides |
Q. Abdool Karim |
|
|
|
Trial participation disclosure in the CAPRISA 004 Tenofovir gel trial |
S. Succop |
|
|
|
Session 2: HIV prevention for Women (2) |
|||
|
Use of survey and video to increase uptake of long-term family planning methods in Zambian Cohort in preparation for HIV prevention studies |
D. Sitrin |
|
|
|
Scaling up couples counseling and testing in Rwanda National HIV Program |
A. Ahayo |
N.A |
|
|
HIV screening in the emergency department: Does testing methodology impact the refusal rate in women screened? |
S. Isom |
|
|
|
The impact of expanding access to HAART on fertility intentions, contraceptive use, and fertility among women in an HIV hyper-endemic setting |
A. Kaida |
|
|
|
Session 3: Learning from each other: what cohorts of women are available |
|||
|
Invited lecture: Overview of cohorts of HIV-infected women and girls |
M. Gandhi |
|
|
|
Threat to success in women: toxicity and failure. Long-term-results from the Chilean AIDS Cohort (ChiAC) |
P. Vasquez |
|
|
|
Violence among a cohort of HIV-positive women on antiretroviral therapy in British Columbia, Canada |
A. Palmer |
|
|
|
Women with a history of injection drug use at greatest risk for poorer clinical outcomes in a cohort of HIV-positive individuals in Canada |
A. Cescon |
|
|
|
HPTN 064 (ISIS): Identifying and retaining US women at greatest risk of HIV infection |
D. Haley |
|
|
a Medical Education company
